Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

July 12, 2016July 12, 2016

Water Channel Protein May Help to Diagnose Malignant Mesothelioma

News

Researchers have found that a protein, named Aquaporin 1 (AQP1), is a valuable biomarker in malignant mesothelioma patients. The study, “Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective ... Read more

May 19, 2016May 19, 2016

Family History of Mesothelioma Raises a Person’s Risk for the Disease, Study Reports

News

A population-based study from Sweden found that a family history of mesothelioma, specifically in parents and siblings, is a risk factor for mesothelioma in a person. The study, “Incidence and familial risk of ... Read more

May 6, 2016May 6, 2016

MicroRNA Reported to Halt Growth of Malignant Mesothelioma Tumors in Mouse Model

News

A small RNA molecule, microRNA-126 (MIR126), has a protective role in malignant mesothelioma mouse models by triggering a cellular pathway, called autophagy, that leads to the metabolic reprogramming of cancer cells and ... Read more

April 26, 2016April 26, 2016

Mesothelioma’s Likely Response to Mitochondria-Targeted Therapy Is Predictable, Study Reports

News

Researchers assessing the morphology of mitochondria using two novel approaches, fractal dimension and lacunarity analysis, reported that mitochondria inhibition is a potential new therapeutic approach in mesothelioma, and that mitochondrial morphology is a likely predictor of response to such therapies. ... Read more

April 20, 2016April 20, 2016

Study Identifies 2 Serum Biomarkers That Might Quickly Detect Malignant Mesothelioma Caused by Asbestos Exposure

News

Two serum biomarkers, soluble mesothelin-related peptide (SMRP) and thioredoxin-1 (TRX), were identified as potentially useful for an early diagnosis of malignant pleural mesothelioma, according to the study, “Evaluation of New ... Read more

April 19, 2016April 19, 2016

MicroRNA Is Altered in Specific Malignant Pleural Mesotheliomas, Study Finds

News

A research team reported that microRNAs (miRNAs) are differentially regulated between malignant pleural mesotheliomas that are positive for MDM2 compared to ones that are MDM2-negative. The study, published in the journal ... Read more

April 4, 2016April 4, 2016

Mesothelioma and Other Malignancies Readily Identified in Study by Protein Biomarkers in Patients’ Pleural Effusions

News

A combination of protein biomarkers may effectively distinguish malignant from non-malignant pleural effusions, according to the results of a recent study, “Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate ... Read more

March 28, 2016March 31, 2016

MesobanK UK, a Tissue and Data Bank, to Promote Mesothelioma Research and Treatment

News

A new bioresource, MesobanK UK, comprising hundreds of pleural mesothelioma tissue samples and linked to detailed but anonymous clinical data, has been established to advance research worldwide into the mechanisms underlying malignant pleural mesothelioma ... Read more

March 24, 2016March 24, 2016

First Case Report Published of Malignant Mesothelioma Found Positive for TTF-1 Expression

News

In a recent study titled “Positive TTF-1 Expression in Malignant Mesothelioma: A Case Report” and published in the American Journal of Case Reports, the study’s authors report the first case of ... Read more

February 11, 2016February 11, 2016

In Malignant Pleural Mesothelioma, New Mutations in Gene Identified, Potentially Leading to Future Therapies

News

Frequent mutations in the SETDB1 gene and genome-wide alterations of allelic loss were identified in malignant pleural mesothelioma, according to results of a recent study, “Whole exome and targeted deep ... Read more